FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/24275

Title:	FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.
Authors:	Engel, FB Hsieh, PC Lee, RT Keating, MT
Issue Date:	2006
Relation:	Proceedings of the National Academy of Sciences of the United States of America 103(42), 15546-15551
URI:	http://ir.sinica.edu.tw/handle/201000000A/24275
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0027-8424&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://www.ncbi.nlm.nih.gov/pubmed/17032753
Appears in Collections:	生物醫學科學研究所

Show full item record

Last Week
0

Last month
1

checked on May 9, 2025

Check